Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous platelet-rich plasma for women with Asherman's syndrome
IRCT20110509006420N17Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jul 2018
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of autologous platelet-rich plasma in Intrauterine Adhesions (IUA) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Adhesion scoring. Started Jul 2018; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on IRCT20110509006420N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110509006420N17.